View : 282 Download: 0
CHOP deficiency prevents methylglyoxal-induced myocyte apoptosis and cardiac dysfunction
- CHOP deficiency prevents methylglyoxal-induced myocyte apoptosis and cardiac dysfunction
- Nam, Dae-Hwan; Han, Jung-Hwa; Lee, Tae-Jin; Shishido, Tetsuro; Lim, Jae Hyang; Kim, Geun-Young; Woo, Chang-Hoon
- Ewha Authors
- SCOPUS Author ID
- Issue Date
- Journal Title
- JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY vol. 85, pp. 168 - 177
- Methylglyoxal; CHOP; ER stress; Diabetes; Cardiac dysfunction
- ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
- SCIE; SCOPUS
- Document Type
- Epidemiological studies indicate that methylglyoxal (MGO) plasma levels are closely linked to diabetes and the exacerbation of diabetic cardiovascular complications. Recently, it was established that endoplasmic reticulum (ER) stress importantly contributes to the pathogenesis of diabetes and its cardiovascular complications. The objective of this study was to explore the mechanism by which diabetes instigates cardiomyocyte apoptosis and cardiac dysfunction via MGO-mediated myocyte apoptosis. Intriguingly, the MGO activated unfolded protein response pathway accompanying apoptotic events, such as cleavages of PARP-1 and caspase-3. In addition, Western blot analysis revealed that MGO-induced myocyte apoptosis was inhibited by depletion of CHOP with siRNA against Ddit3, the gene name for rat CHOP. To investigate the physiologic roles of CHOP in vivo, glucose tolerance and cardiac dysfunction were assessed in CHOP-deficient mice. No significant difference was observed between CHOP KO and littermate naive controls in terms of the MGO-induced impairment of glucose tolerance. In contrast, myocyte apoptosis, inflammation, and cardiac dysfunction were significantly diminished in CHOP KO compared with littermate na ve controls. These results showed that CHOP is the key signal for myocyte apoptosis and cardiac dysfunction induced by MGO. These findings suggest a therapeutic potential of CHOP inhibition in the management of diabetic cardiovascular complications including diabetic cardiomyopathy. (C) 2015 Elsevier Ltd. All rights reserved.
- Appears in Collections:
- 의과대학 > 의학과 > Journal papers
- Files in This Item:
There are no files associated with this item.
- RIS (EndNote)
- XLS (Excel)
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.